Jim Cramer Rejects UiPath Despite Cheap Valuation, Backs Affirm
Cramer called UiPath cheap but lacking catalysts, endorsed Karman and Affirm, warned on Onto and Nio, and favored Regeneron, Vertex and Amgen over Alnylam
Follow the latest Onto Innovation Inc. (ONTO) news and market headlines alongside the live ONTO price. Stay informed on what's moving ONTO.
Cramer called UiPath cheap but lacking catalysts, endorsed Karman and Affirm, warned on Onto and Nio, and favored Regeneron, Vertex and Amgen over Alnylam
Onto Innovation reported record Q3 revenues of $409.7M (up 87.8% YoY) and non-GAAP EPS of $2.44 (up 165.2%), with a $1.3B backlog supporting growth through mid-2027. However, the stock trades at an 8.2X EV/sales premium and faces risks from 57.1% customer concentration among four clients and rising inventory costs.
Onto Innovation (ONTO) raised its Q4 revenue guidance to $430M-$450M with non-GAAP EPS of $2.59-$2.79, driven by record Q3 results and strong adoption of its Dragonfly G5 and Atlas G6 tools. The company's $1.3B backlog with orders extending into 2028 signals sustained demand from AI-related semiconductor investments in advanced packaging and advanced nodes.
Onto Innovation reported Q3 revenues of $409.7M (up 87.8%) and non-GAAP earnings of $2.44 per share (up 165.2%), with advanced-packaging revenue expected to grow over 80% in 2026. However, the stock trades at an 8.2X EV/sales premium above its historical median, and return on invested capital of 9.7% lags its 10-year average, suggesting investors should exercise selectivity on entry price despite strong growth visibility.
Onto Innovation (ONTO) delivered improved Q3 2026 results with operating cash flow rising to $79M and revenues surging 88% year-over-year to $410M. The company maintains a $1.3B backlog and projects sequential revenue growth through H1 2027. However, nine-month operating cash flow declined to $166.6M from $233.3M due to higher inventories and collection timing. Competitors KLA and Nova also showed strong performance in semiconductor equipment demand.
Onto Innovation achieved a non-GAAP gross margin of 57.6% in Q3 2026, up 300 basis points from Q4 2025, driven by operational efficiencies and manufacturing improvements. Q3 revenues surged nearly 90% year-over-year to $410 million, fueled by strong advanced packaging demand. The company expects Q4 gross margin above 58% and revenues of $430-$450 million, with continued margin expansion anticipated in 2027.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to ONTO, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.